Highlights from the 25th National GEDO Day – Biomedicine Agency
Biomedicine Agency shared a post on LinkedIn:
“A look back at the Agency’s participation in the 25th National GEDO Day
The Biomedicine Agency is delighted to have been able to participate in this anniversary edition of the Study Group for Egg Donation (GEDO) around the common thread ‘Evidence and uncertaint'”.
During the workshop dedicated to regulatory aspects in oocyte donation and ovarian failure:
- Chloé Baron and Samuel Arrabal took a concrete look at the European SoHO regulation applied to multidisciplinary egg donation platforms.
- Dr. Claire de Vienne shared his vision on secondary egg donation in France, shedding light on the essential role of private centers in donation pathways.
Their interventions have fuelled debates, provoked reflections and strengthened our conviction: combining scientific rigour, ethics and solidarity is essential to advance biomedicine for the benefit of patients.
A big thank you to the GEDO and the organizers for their welcome, the quality of the exchanges and this strong moment of co-construction.
To find out more about egg donation.”
-
Oct 29, 2026, 15:58Eric Lameignere: Can DNA Fragmentation in Cumulus Cells Predict ICSI Outcomes?
-
Oct 29, 2026, 15:50Saadat Hassan: Sperm Function Testing – Can Advanced Diagnostics Guide IVF and ICSI Selection?
-
Oct 29, 2026, 15:34Sara Spiro: Celebrating the Stories Members Have Trusted With at Maven Clinic – Here Is Mine
-
Oct 29, 2026, 15:31Dina Ibrahem: 0 Motility, 1 Critical Decision
-
Oct 29, 2026, 15:28AI and Automation in Fertility and Genomics: Pipeline or Pipe Dream? – ARCS
-
Oct 29, 2026, 15:26Michael Schindler: Large Networks or Small Centers – Who Delivers Better Care?
-
Oct 29, 2026, 15:24Denny Sakkas: Driving Innovation in Reproductive Medicine
-
Oct 29, 2026, 15:10From the President’s Gala to Booth 905 at ASRM 2026 – First Fertility
-
Oct 29, 2026, 15:04Proud to Spotlight Dr. Jannie Michielsen and the Expertise She Brings to Every Day – Sims IVF